日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Doravirine-based Regimens by Sex and Race: Long-term Results From Three Phase 3 Clinical Trials

多拉韦林治疗方案的疗效和安全性按性别和种族划分:三项3期临床试验的长期结果

Walmsley, Sharon L; Kumar, Princy N; Orkin, Chloe; Thompson, Melanie; Squires, Kathleen; Xu, Zhi Jin; Greaves, Wayne; Plank, Rebeca M; Whiteside, Yohance; Lahoulou, Rima

Factors Associated With Weight Change After Continuing or Switching to a Doravirine-based Regimen

影响继续或改用多拉韦林治疗方案后体重变化的因素

Orkin, Chloe; Koethe, John R; Kumar, Princy N; Sklar, Peter; Xu, Zhi Jin; Plank, Rebeca M; Greaves, Wayne; Lahoulou, Rima

Brief Report: Resolution of Neuropsychiatric Adverse Events After Switching to a Doravirine-Based Regimen in the Open-Label Extensions of the DRIVE-AHEAD and DRIVE-FORWARD Trials

简报:在 DRIVE-AHEAD 和 DRIVE-FORWARD 试验的开放标签扩展研究中,改用基于多拉韦林的治疗方案后,神经精神不良事件得到缓解

Moyle, Graeme; Meng, Fanxia; Wan, Hong; Sklar, Peter; Plank, Rebeca M; Lahoulou, Rima

Brief Report: Exploratory Substudy of a Phase 2 Trial to Evaluate the Pharmacokinetic Effect of Once-Monthly Islatravir on Long-Acting Reversible Contraceptives

简报:一项评估每月一次注射伊斯拉曲韦对长效可逆避孕药药代动力学影响的 II 期试验的探索性子研究

Pham, Michelle; Wickremasingha, Prachi; Vargo, Ryan; Patel, Munjal; Nedrow, Katherine; Homony, Brenda; Robertson, Michael N; Plank, Rebeca M

Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1

每月一次口服伊斯拉曲韦的安全性、耐受性和药代动力学:一项针对1型人类免疫缺陷病毒感染低风险人群的2a期研究

Hillier, Sharon L; Bekker, Linda-Gail; Riddler, Sharon A; Hendrix, Craig W; Badal-Faesen, Sharlaa; Macdonald, Pippa; Nair, Gonasagrie; Lombaard, Johannes; Caraco, Yoseph; Peer, Avivit; Patel, Munjal; Vargo, Ryan; Homony, Brenda; Nedrow, Katherine; Evans, Barbara; Wickremasingha, Prachi; Zhou, Yun-Ping; Teal, Valerie; Hwang, Peggy; McMullan, Ciaran; Kaufman, Keith D; Robertson, Michael N; Plank, Rebeca M

Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor.

从依非韦伦换用整合酶抑制剂相关的免疫学和神经代谢物变化

Asundi Archana, Robles Yvonne, Starr Tyler, Landay Alan, Kinslow Jennifer, Ladner Joshua, White Laura, Plank Rebeca M, Melbourne Kathleen, Weisholtz Daniel, Bennett Monica, Pan Hong, Stern Emily, Lin Alexander, Kuritzkes Daniel R, Lin Nina H

Field evaluation of the safety, acceptability, and feasibility of early infant male circumcision using the AccuCirc device

使用 AccuCirc 设备对男婴早期包皮环切术进行安全性、可接受性和可行性的现场评估

Bailey, Robert C; Nyaboke, Irene; Mackesy-Amiti, Mary Ellen; Okello, Erick; Pengo, Valentine; Ochomo, Betha; Auma, Mary Emmaculate; Were, Simon; Ojuok, Stella; Adoyo, Evelyne; Adhiambo, Mildred; Young, Marisa R; Plank, Rebeca M; Otieno, Fredrick O

Vitamin K deficiency bleeding and early infant male circumcision in Africa

非洲维生素K缺乏性出血和男婴早期割礼

Plank, Rebeca M; Steinmetz, Tara; Sokal, David C; Shearer, Martin J; Data, Santorino

Loss of anatomical landmarks with eutectic mixture of local anesthetic cream for neonatal male circumcision

新生儿男性包皮环切术中使用局部麻醉霜共晶混合物导致解剖标志消失

Plank, Rebeca M; Kubiak, David W; Abdullahi, Rasak Bamidele; Ndubuka, Nnamdi; Nkgau, Maggie M; Dapaah-Siakwan, Fredrick; Powis, Kathleen M; Lockman, Shahin

Acceptability of infant male circumcision as part of HIV prevention and male reproductive health efforts in Gaborone, Botswana, and surrounding areas

在博茨瓦纳首都哈博罗内及其周边地区,男婴包皮环切术作为艾滋病毒预防和男性生殖健康措施的可接受性

Plank, Rebeca M; Makhema, Joseph; Kebaabetswe, Poloko; Hussein, Fatima; Lesetedi, Chiapo; Halperin, Daniel; Bassil, Barbara; Shapiro, Roger; Lockman, Shahin